EFFICACY AND SAFETY OF RE-INDUCTION TREATMENT WITH THE SELECTIVE IL-23 INHIBITOR RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN?S DISEASE

Brian G. Feagan  1     William Sandborn  2     Julian Panés  3     Marc Ferrante  4     Edouard Louis  5     Geert R. D'Haens  6     Denis Franchimont  7     Arthur Kaser     Olivier Dewit     Ursula Seidler     Kyung-Jo Kim     Markus F. Neurath     Paul Scholl     Sudha Visvanathan     Steven J Padula     Ivona Herichova     Nanshi Sha     David Hall     Wulf O. Böcher    
1 Robarts Clinical Trials, London, Canada
2 University of California San Diego, La Jolla, United States of America
3 Hospital Clinic Barcelona, Barcelona, Spain
4 University Hospitals Leuven, Leuven, Belgium
5 University Hospital CHU Liège, Liège, Belgium
6 Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
7 Erasme Uni

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing